Krones

EQS-News: Krones AG: Krones appoints new chairman of Audit and Risk Management Committee as basis for return to DAX index family

Retrieved on: 
Lunedì, Settembre 25, 2023

Matthias Winkler to succeed Norbert Broger as chairman of the Audit and Risk Management Committee of the Supervisory Board of Krones AG.

Key Points: 
  • Matthias Winkler to succeed Norbert Broger as chairman of the Audit and Risk Management Committee of the Supervisory Board of Krones AG.
  • In an extraordinary meeting, the Audit and Risk Management Committee of the Supervisory Board of Krones AG elected Matthias Winkler as its new chairman.
  • Mr. Broger is to remain a member of the Audit and Risk Management Committee of the Supervisory Board of Krones AG.
  • Krones AG shares will consequently then be a candidate for a return to the Deutsche Börse AG DAX index family.

EQS-News: Krones AG: Krones to clear the way for a quick return to the DAX index family

Retrieved on: 
Mercoledì, Settembre 6, 2023

With effect from 18 September 2023, Krones AG shares will no longer be listed in the MDAX index.

Key Points: 
  • With effect from 18 September 2023, Krones AG shares will no longer be listed in the MDAX index.
  • This is an outcome of the periodic review of the DAX index family by Deutsche Börse AG on 5 September 2023.
  • As Krones shares will also not become a component of the SDAX index, they are set to leave the DAX index family altogether on 18 September 2023.
  • Membership in the Deutsche Börse AG DAX index family has a very high priority for the Executive Board and Supervisory Board of Krones AG.

EQS-News: Krones AG: Krones with successful first half-year 2023

Retrieved on: 
Martedì, Agosto 1, 2023

Krones has raised its guidance for revenue growth in the full year 2023.

Key Points: 
  • Krones has raised its guidance for revenue growth in the full year 2023.
  • Krones therefore expects order intake to continue developing well at a normalised level in the second half of 2023.
  • As a result of the continued strong demand, Krones’ order backlog further increased despite the higher output in the first half of 2023.
  • In the second quarter of 2023, Krones’ EBITDA increased by 20.9 % year on year to €106.5 million.

EQS-News: Krones AG: Krones shares move up to MDAX index

Retrieved on: 
Sabato, Giugno 10, 2023

Deutsche Börse AG announced its decision yesterday evening on the new composition of the DAX index family with effect from 19 June 2023.

Key Points: 
  • Deutsche Börse AG announced its decision yesterday evening on the new composition of the DAX index family with effect from 19 June 2023.
  • The DAX, MDAX, SDAX and TecDAX indices were reviewed on the basis of the Fast Exit and Fast Entry rules.
  • As a result of the periodic review, Krones AG shares are to be promoted from the SDAX to the MDAX index.
  • After five years in the SDAX, Krones is thus returning to the MDAX, Germany’s midcap index comprising 50 companies.

EQS-News: Krones AG: Krones made a very good start to the 2023 financial year

Retrieved on: 
Venerdì, Maggio 5, 2023

Based on the positive first-quarter trend, Krones is confident of meeting the forecast for 2023.

Key Points: 
  • Based on the positive first-quarter trend, Krones is confident of meeting the forecast for 2023.
  • The strong demand means that Krones’ order backlog further increased in the first three months of 2023.
  • Krones’ revenue from January to March 2023 increased by a substantial 21.4% year on year, from €987.2 million to €1,198.8 million.
  • At group level, Krones is forecasting an EBITDA margin of 9% to 10% for 2023 (2022: 8.9%).

EQS-News: Krones AG: Krones expands its capabilities in process technology with the acquisition of US company Ampco Pumps

Retrieved on: 
Venerdì, Aprile 21, 2023

On 20th of April 2023, Krones has signed an agreement to acquire 90% of Ampco Pumps Company LLC (Ampco Pumps).

Key Points: 
  • On 20th of April 2023, Krones has signed an agreement to acquire 90% of Ampco Pumps Company LLC (Ampco Pumps).
  • The acquisition of Ampco Pumps is a major step in expanding the components business of Krones Processing.
  • With Ampco Pumps and Evoguard Valve Technology Krones has now a broad portfolio of all key components for the processing technology market.
  • As of the closing date, Krones will consolidate the figures of Ampco Pumps in the "Process Technology" segment.

Krones Selects Icertis to Digitally Transform Contract Management

Retrieved on: 
Martedì, Aprile 11, 2023

FRANKFURT, Germany, April 11, 2023 /PRNewswire/ -- Icertis , the contract intelligence company that pushes the boundaries of what's possible with contract lifecycle management (CLM), today announced that Krones has selected Icertis Contract Intelligence (ICI) to digitally transform its contracting processes for sales and procurement operations across the enterprise.

Key Points: 
  • FRANKFURT, Germany, April 11, 2023 /PRNewswire/ -- Icertis , the contract intelligence company that pushes the boundaries of what's possible with contract lifecycle management (CLM), today announced that Krones has selected Icertis Contract Intelligence (ICI) to digitally transform its contracting processes for sales and procurement operations across the enterprise.
  • Icertis will streamline and unify contract management for the company's headquarters in Neutraubling, enabling increased visibility and compliance with contractual obligations across both buy-side and sell-side contracts.
  • German packaging and bottling machine manufacturer Krones will integrate ICI with SAP Ariba and Salesforce to connect contract data to core systems and unlock enterprise-wide intelligence.
  • "The power of Icertis Contract Intelligence integrated with SAP Ariba and Salesforce will help Krones achieve greater visibility, efficiency, and insights while optimizing commercial relationships."

EQS-News: Krones AG: Krones to increase dividend for 2022 by 25% to €1.75 per share

Retrieved on: 
Giovedì, Marzo 23, 2023

At the Annual General Meeting for 2022, the Executive Board and Supervisory Board will propose a dividend of €1.75 per share (previous year: €1.40 per share).

Key Points: 
  • At the Annual General Meeting for 2022, the Executive Board and Supervisory Board will propose a dividend of €1.75 per share (previous year: €1.40 per share).
  • Krones thus exceeded the upgraded growth target of 10% to 12% published in October 2022 (original target 5% to 8%).
  • On the bottom line, Krones generated consolidated net income of €187.1 million in 2022, an increase of 32.3% (previous year: €141.4 million).
  • Thanks to the company’s innovative solutions and good project work with customers, Krones succeeded in implementing price increases in 2022.

EQS-News: Krones AG: Krones verbesserte 2022 alle wesentlichen Finanzkennzahlen und prognostiziert für 2023 weiteres Umsatz- und Ergebniswachstum

Retrieved on: 
Giovedì, Febbraio 23, 2023

The company generated free cash flow of €371.0 million in 2022 (previous year: €203.3 million).

Key Points: 
  • The company generated free cash flow of €371.0 million in 2022 (previous year: €203.3 million).
  • Krones thus exceeded the upgraded growth target of 10% to 12% published in October 2022 (original target 5% to 8%).
  • Due to the extensive measures taken to increase efficiency, Krones’ profitability improved in 2022 despite rising material and freight costs.
  • For the third performance target, return on capital employed (ROCE), Krones expects an increase to between 15% and 17% in 2023.

EQS-News: Krones AG: Krones expands its capabilities in the growing pharmaceutical market with the acquisition of US company R+D Custom Automation

Retrieved on: 
Venerdì, Novembre 11, 2022

Krones, a leading manufacturer of filling and packaging solutions, has acquired 80.5% of R+D Custom Automation LLC (R+D) with effect from 8 November 2022.

Key Points: 
  • Krones, a leading manufacturer of filling and packaging solutions, has acquired 80.5% of R+D Custom Automation LLC (R+D) with effect from 8 November 2022.
  • Based in Wisconsin, USA, R+D supplies machinery and equipment for the production and filling of containers for the pharmaceutical industry.
  • It strengthens Krones activities in the attractive life science and pharmaceutical market, which shows above-average growth.
  • In R+D, Krones also gains a highly experienced team with innovative solutions and good customer relationships with established pharmaceutical groups.